You just read:

Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF)

News provided by

Celtaxsys, Inc.

Jul 06, 2015, 08:03 ET